VITL:NASDAQVital Farms, Inc. Analysis
Data as of 2026-07-29 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Vital Farms trades around $13.70, comfortably above its 20‑day SMA of ~13.10 but still below the 50‑day SMA of ~11.4, while the 200‑day SMA sits near $21.7, signaling a long‑term downtrend. Momentum indicators are mixed: RSI is in the low 60s, suggesting the stock is approaching overbought levels, and the MACD histogram has turned negative, giving a bearish signal. Volatility is elevated at roughly 53% over the past month and beta hovers near 1.0, indicating market‑aligned price swings. Fundamentally, revenue is growing at about 15% year‑over‑year, yet operating margins are negative and free cash flow is deeply in the red, while debt remains modest relative to equity. A discounted cash‑flow model values the company near $3.90, implying a downside of more than 12% from current levels, and analysts’ consensus remains a “buy” despite these red flags. Recent news shows a short‑term price rally of nearly 6% on sector‑wide optimism after General Mills’ strong results, followed by a pullback to the low $12s, underscoring the stock’s sensitivity to broader consumer‑staples sentiment.
Market Outlook
Short Term
< 1 yearKey Factors
- Bearish MACD histogram and proximity to resistance around $14.05
- High short‑term volatility and recent price swing from $12.78 to $13.68
- Positive earnings per share but negative free cash flow
Medium Term
1–3 yearsKey Factors
- Revenue growth of ~15% offset by negative operating margins
- DCF fair value far below market price, indicating overvaluation
- Stable volume and modest debt but continued cash‑flow deficits
Long Term
> 3 yearsKey Factors
- Significant valuation gap (market price vs. $3.90 DCF estimate)
- Persistent free‑cash‑flow negativity and margin compression
- Elevated volatility and market‑aligned beta suggesting limited downside protection
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.